Gordon Loewen
Impact in
- Biochemistry top 5%
- Antioxidant Activity and Oxidative Stress
Papers in
-
- Retinoids in leukemia and cellular processes 10
- Nicotinic Acetylcholine Receptors Study 3
-
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Roger K. Verbeeck (2 shared papers)J.L. Blackburn (1 shared paper)J A Truglia (6 shared papers)James R. Rigas (3 shared papers)Mark G. Kris (2 shared papers)Francesca Benedetti (2 shared papers)George M. Gill (3 shared papers)E H Ulm (3 shared papers)
- Journals
- Journal of Clinical Oncology (3 papers)Alzheimer s & Dementia (2 papers)Pain Medicine (2 papers)Neurology (2 papers)Blood (1 paper)
- Partner nations
- United StatesCanadaIreland
In The Last Decade
Gordon Loewen
38 papers receiving 829 citations
Peers
Comparison fields: 5 of 85
- Biochemistry 85
- Anesthesiology and Pain Medicine 47
- Dermatology 78
- Pharmacology 148
- Pharmacology 76
Countries citing papers authored by Gordon Loewen
This map shows the geographic impact of Gordon Loewen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Loewen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Loewen more than expected).
Fields of papers citing papers by Gordon Loewen
This network shows the impact of papers produced by Gordon Loewen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Loewen. The network helps show where Gordon Loewen may publish in the future.
Co-authors
The 25 scholars most cited alongside Gordon Loewen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1983 | 185 | |
| 2 | 1997 | 158 | |
| 3 | A Phase I study of LGD1069 in adults with advanced cancer. | 1999 | 88 |
| 4 | Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid. | 1996 | 55 |
| 5 | 2016 | 53 | |
| 6 | 2002 | 46 | |
| 7 | 2000 | 46 | |
| 8 | 2012 | 34 | |
| 9 | 2017 | 27 | |
| 10 | Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer. | 1998 | 23 |
| 11 | 1989 | 22 | |
| 12 | 2011 | 20 | |
| 13 | 2002 | 13 | |
| 14 | 2002 | 13 | |
| 15 | 2007 | 12 | |
| 16 | 2000 | 12 | |
| 17 | 2019 | 8 | |
| 18 | 2007 | 7 | |
| 19 | 2022 | 7 | |
| 20 | 1998 | 6 |
About Gordon Loewen
Gordon Loewen is a scholar working on Molecular Biology, Pharmacology, Cellular and Molecular Neuroscience, Oncology and Pharmacology, having authored 39 papers that have together received 870 indexed citations. Recurring topics across this work include Retinoids in leukemia and cellular processes (10 papers), Neuroscience and Neuropharmacology Research (4 papers), Estrogen and related hormone effects (4 papers), Pain Management and Opioid Use (3 papers), Cancer Treatment and Pharmacology (3 papers), Nicotinic Acetylcholine Receptors Study (3 papers), Antioxidant Activity and Oxidative Stress (3 papers) and Pharmacogenetics and Drug Metabolism (3 papers). The work is most often cited by research in Biochemistry (85 citations), Anesthesiology and Pain Medicine (47 citations), Dermatology (78 citations), Pharmacology (148 citations) and Pharmacology (76 citations). Gordon Loewen has collaborated with scholars based in United States, Canada and Ireland. Frequent co-authors include Roger K. Verbeeck, J.L. Blackburn, J A Truglia, James R. Rigas, Mark G. Kris, Francesca Benedetti, George M. Gill, E H Ulm, Lise Eliot and Daniel A. Straus. Their work appears in journals such as Journal of Clinical Oncology, Alzheimer s & Dementia, Pain Medicine, Neurology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.